首页 > 最新文献

Medycyna doswiadczalna i mikrobiologia最新文献

英文 中文
[Occurence of pili genes in Corynebacterium diphtheriae strains]. 白喉棒状杆菌菌毛基因的出现。
Aleksandra Anna Zasada, Kamila Formińska, Magdalena Rzeczkowska

Introduction: Adhesion of pathogenic bacteria to host cells is a crucial step during infection. The presence of specific adhesion factors on the bacterial cell surface determines the tropism of the pathogen to the tissues expressing certain surface receptors. The adhesion is mediated primarily by filamentous structures called pili. Three distinct pilus structures can be produced by Corynebacterium diphtheriae: SpaA-, SpaD- and SpaH-type pili. Pilus genes encode a total of nine pilus proteins, named SpaA through SpaI, and six sortases, named SrtA through SrtF. All the pilus genes are located on pathogenicity islands and can be acquired and lost by different strains. The aim of presented studies was assessment of occurence of pili genes among C. diphtheriae strains isolated from different infections, including invasive infections, in Poland.

Methods: Thirty-one toxigenic and nontoxigenic C. diphtheriae strains isolated from wounds, blood, nose and pharynx were investigated for presence of 15 pili genes. The studies were conducted using PCR. Gene specific primers were designed on the basis of the complete genome sequence of C. diphtheriae NCTC 13129.

Result: All the nontoxigenic C. diphtheriae strains isolated from invasive infections possess every tested genes in contrast to toxigenic strains that revealed highly mosaic structure of pili gene clusters. Differences in gene content were detected in SpaA- and SpaH-type pili gene clusters. Complete set of genes in SpaD-type pili gene cluster was detected in all but two strains. The two strains did not possess any of SpaD-type pili genes.

Conclusions: Invasiveness of C. diphtheriae strains could be related to adhesive factors. Results of our studies suggest that ability to express all types of pili is indispensable for causing invasive infections by nontoxigenic C. diphtheriae. Whereas full set ofpili genes is not necessary for causing classical diphtheria.

病原菌与宿主细胞的粘附是感染过程中的关键步骤。细菌细胞表面特定粘附因子的存在决定了病原体对表达某些表面受体的组织的趋向性。粘连主要是由称为毛的丝状结构介导的。白喉棒状杆菌可产生三种不同的菌毛结构:SpaA型、SpaD型和spah型菌毛。毛菌基因共编码9种毛菌蛋白,命名为SpaA至SpaI,以及6种排序酶,命名为SrtA至SrtF。所有菌毛基因均位于致病岛上,不同菌株可获得或丢失菌毛基因。提出的研究的目的是评估在波兰从不同感染分离的白喉菌株中毛基因的发生率,包括侵袭性感染。方法:对从伤口、血液、鼻、咽分离的31株产毒株和非产毒株进行毛毛基因检测。研究采用PCR进行。根据白喉白喉杆菌NCTC 13129全基因组序列设计基因特异性引物。结果:从侵入性感染中分离得到的非产毒株均具有所有检测基因,而产毒株的毛基因簇呈高度镶嵌结构。在SpaA型和spah型毛基因簇中检测到基因含量的差异。除2株菌株外,其余菌株均检出完整的spad型菌毛基因簇。两株菌均不含spad型菌毛基因。结论:白喉链球菌的侵袭性可能与黏附因子有关。我们的研究结果表明,表达所有类型毛的能力对于引起非产毒素白喉支原体的侵袭性感染是必不可少的。而全套毛菌基因并不是引起典型白喉的必要条件。
{"title":"[Occurence of pili genes in Corynebacterium diphtheriae strains].","authors":"Aleksandra Anna Zasada,&nbsp;Kamila Formińska,&nbsp;Magdalena Rzeczkowska","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Adhesion of pathogenic bacteria to host cells is a crucial step during infection. The presence of specific adhesion factors on the bacterial cell surface determines the tropism of the pathogen to the tissues expressing certain surface receptors. The adhesion is mediated primarily by filamentous structures called pili. Three distinct pilus structures can be produced by Corynebacterium diphtheriae: SpaA-, SpaD- and SpaH-type pili. Pilus genes encode a total of nine pilus proteins, named SpaA through SpaI, and six sortases, named SrtA through SrtF. All the pilus genes are located on pathogenicity islands and can be acquired and lost by different strains. The aim of presented studies was assessment of occurence of pili genes among C. diphtheriae strains isolated from different infections, including invasive infections, in Poland.</p><p><strong>Methods: </strong>Thirty-one toxigenic and nontoxigenic C. diphtheriae strains isolated from wounds, blood, nose and pharynx were investigated for presence of 15 pili genes. The studies were conducted using PCR. Gene specific primers were designed on the basis of the complete genome sequence of C. diphtheriae NCTC 13129.</p><p><strong>Result: </strong>All the nontoxigenic C. diphtheriae strains isolated from invasive infections possess every tested genes in contrast to toxigenic strains that revealed highly mosaic structure of pili gene clusters. Differences in gene content were detected in SpaA- and SpaH-type pili gene clusters. Complete set of genes in SpaD-type pili gene cluster was detected in all but two strains. The two strains did not possess any of SpaD-type pili genes.</p><p><strong>Conclusions: </strong>Invasiveness of C. diphtheriae strains could be related to adhesive factors. Results of our studies suggest that ability to express all types of pili is indispensable for causing invasive infections by nontoxigenic C. diphtheriae. Whereas full set ofpili genes is not necessary for causing classical diphtheria.</p>","PeriodicalId":18521,"journal":{"name":"Medycyna doswiadczalna i mikrobiologia","volume":"64 1","pages":"19-27"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30772179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Occurrence of alert pathogens in hospital environment. Part I. ESBL-producing enterobacteriaceae strains]. 医院环境中高危病原体的发生。第一部分:产esbl肠杆菌科菌株。
Paulina Paluchowska, Małgorzata Skałkowska, Anna Spelak, Alicja Budak

Introduction: Gram-negative bacteria belonging to the family Enterobacteriaceae cause severe and difficult to treat nosocomial infections. Strains of different species that produce extended-spectrum beta-lactamases (ESBL) were classified as alert pathogens. The purpose of this study was to analyze the occurrence and determination of antimicrobial susceptibility patterns of 134 ESBL-producing Enterobacteriaceae strains.

Methods: 96 (72%) isolates of Klebsiella pneumoniae and 38 (28%) isolates of Escherichia coli, were cultured from patients of Specialistic Hospital in Krakow, in the period from 2008 to 2010. Bacterial identification and antimicrobial susceptibility testing were performed by automated system Vitek 2 Compact (bioMerieux, Poland). Condition for inclusion in the study was the production by the strains of beta-lactamases with extended substrate spectrum (ESBL), which was confirmed using the automated method (Vitek 2 Compact system) and the disc-diffusion assay (DDST). Taken into consideration the first isolate from the patient.

Results: Bacilli of the species K. pneumoniae ESBL(+) were mainly isolated from respiratory tract samples (46%), urine (27%) and blood (12%). The dominant divisions in terms of frequency of isolation of these pathogens were anesthesiology and intensive care (42%), neurology and brain strokes (16%) and internal medicine (11%). Drugs with the highest efficiency against K. pneumoniae ESBL(+), in our in vitro studies, were: imipenem (100%), meropenem (100%), amikacin (90%) and tetracycline (75%). E. coli ESBL(+) isolates derived from patients of Anesthesiology and Intensive Care Unit (32%), Internal Medicine Unit (16%) and Division of Hematology (13%). Among all tested strains majority were obtained from respiratory tract samples, urine, swabs from wounds and blood (respectively 24%, 24%, 21% and 18%). Isolates of E. coli ESBL(+) demonstrated the greatest susceptibility in case of amikacin (92%) and piperacillin with tazobactam (76%), which suggests the highest activity of that antimicrobials against infections caused by examined strains. None of the analyzed bacilli were resistant to carbapenems.

Conclusions: Our study highlights the importance of characteristics of distribution of ESBL-producing K. pneumoniae and E. coli strains among hospitalized patient. Good antibiotic policies based on antibiotic resistant patterns can decrease the risk of ESBL infection.

革兰氏阴性菌属肠杆菌科,引起严重且难以治疗的医院感染。产生广谱β -内酰胺酶(ESBL)的不同菌株被列为警戒病原体。本研究的目的是分析134株产esbl肠杆菌科菌株的发生情况并测定其药敏模式。方法:2008 - 2010年从克拉科夫市专科医院患者中分离培养肺炎克雷伯菌96株(72%),大肠杆菌38株(28%)。采用Vitek 2 Compact (bioMerieux,波兰)自动系统进行细菌鉴定和药敏试验。纳入研究的条件是具有扩展底物谱(ESBL)的β -内酰胺酶菌株的生产,使用自动化方法(Vitek 2 Compact系统)和圆盘扩散试验(DDST)证实。考虑到患者的第一次分离。结果:肺炎克雷伯菌ESBL(+)主要分离于呼吸道(46%)、尿液(27%)和血液(12%)。从病原菌分离频率来看,主要科室为麻醉科和重症监护科(42%)、神经科和脑中风科(16%)和内科(11%)。在我们的体外研究中,对肺炎克雷伯菌ESBL(+)效率最高的药物是:亚胺培南(100%)、美罗培南(100%)、阿米卡星(90%)和四环素(75%)。大肠杆菌ESBL(+)分离株来源于麻醉和重症监护病房(32%)、内科(16%)和血液科(13%)的患者。在所有检测菌株中,大多数来自呼吸道样本、尿液、伤口拭子和血液(分别为24%、24%、21%和18%)。大肠杆菌ESBL(+)菌株对阿米卡星(92%)和哌西林与他唑巴坦(76%)的敏感性最高,这表明这两种抗菌剂对所检测菌株引起的感染具有最高的活性。所分析的杆菌对碳青霉烯类均无耐药。结论:本研究强调了产esbl肺炎克雷伯菌和大肠杆菌菌株在住院患者中的分布特征的重要性。基于抗生素耐药模式的良好抗生素政策可以降低ESBL感染的风险。
{"title":"[Occurrence of alert pathogens in hospital environment. Part I. ESBL-producing enterobacteriaceae strains].","authors":"Paulina Paluchowska,&nbsp;Małgorzata Skałkowska,&nbsp;Anna Spelak,&nbsp;Alicja Budak","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Gram-negative bacteria belonging to the family Enterobacteriaceae cause severe and difficult to treat nosocomial infections. Strains of different species that produce extended-spectrum beta-lactamases (ESBL) were classified as alert pathogens. The purpose of this study was to analyze the occurrence and determination of antimicrobial susceptibility patterns of 134 ESBL-producing Enterobacteriaceae strains.</p><p><strong>Methods: </strong>96 (72%) isolates of Klebsiella pneumoniae and 38 (28%) isolates of Escherichia coli, were cultured from patients of Specialistic Hospital in Krakow, in the period from 2008 to 2010. Bacterial identification and antimicrobial susceptibility testing were performed by automated system Vitek 2 Compact (bioMerieux, Poland). Condition for inclusion in the study was the production by the strains of beta-lactamases with extended substrate spectrum (ESBL), which was confirmed using the automated method (Vitek 2 Compact system) and the disc-diffusion assay (DDST). Taken into consideration the first isolate from the patient.</p><p><strong>Results: </strong>Bacilli of the species K. pneumoniae ESBL(+) were mainly isolated from respiratory tract samples (46%), urine (27%) and blood (12%). The dominant divisions in terms of frequency of isolation of these pathogens were anesthesiology and intensive care (42%), neurology and brain strokes (16%) and internal medicine (11%). Drugs with the highest efficiency against K. pneumoniae ESBL(+), in our in vitro studies, were: imipenem (100%), meropenem (100%), amikacin (90%) and tetracycline (75%). E. coli ESBL(+) isolates derived from patients of Anesthesiology and Intensive Care Unit (32%), Internal Medicine Unit (16%) and Division of Hematology (13%). Among all tested strains majority were obtained from respiratory tract samples, urine, swabs from wounds and blood (respectively 24%, 24%, 21% and 18%). Isolates of E. coli ESBL(+) demonstrated the greatest susceptibility in case of amikacin (92%) and piperacillin with tazobactam (76%), which suggests the highest activity of that antimicrobials against infections caused by examined strains. None of the analyzed bacilli were resistant to carbapenems.</p><p><strong>Conclusions: </strong>Our study highlights the importance of characteristics of distribution of ESBL-producing K. pneumoniae and E. coli strains among hospitalized patient. Good antibiotic policies based on antibiotic resistant patterns can decrease the risk of ESBL infection.</p>","PeriodicalId":18521,"journal":{"name":"Medycyna doswiadczalna i mikrobiologia","volume":"64 1","pages":"35-43"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30772181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Verocytotoxigenic Escherichia coli--epidemiology, pathogenicity and antimicrobial resistance]. [产巨细胞毒素大肠杆菌——流行病学、致病性和耐药性]。
Aleksandra Januszkiewicz

Verocytotoxigenic E. coli (VTEC) are one of the most common foodborne pathogen in human worldwide. High pathogenic potential of these organisms makes it often the cause of international outbreaks with numerous fatalities. This study presents the current knowledge on verocytotoxigenic E. coli: pathogenicity, drug resistance as well as the epidemiology of infections.

产胞毒素大肠杆菌(VTEC)是世界范围内人类最常见的食源性病原体之一。这些生物的高致病性使其经常成为造成大量死亡的国际疫情的原因。本研究介绍了目前关于巨噬细胞毒素大肠杆菌的知识:致病性,耐药性以及感染的流行病学。
{"title":"[Verocytotoxigenic Escherichia coli--epidemiology, pathogenicity and antimicrobial resistance].","authors":"Aleksandra Januszkiewicz","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Verocytotoxigenic E. coli (VTEC) are one of the most common foodborne pathogen in human worldwide. High pathogenic potential of these organisms makes it often the cause of international outbreaks with numerous fatalities. This study presents the current knowledge on verocytotoxigenic E. coli: pathogenicity, drug resistance as well as the epidemiology of infections.</p>","PeriodicalId":18521,"journal":{"name":"Medycyna doswiadczalna i mikrobiologia","volume":"64 4","pages":"315-36"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31302501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Occurrence of alert pathogens in hospital environment Part II. Multidrug-resistant non-fermenting bacilli]. 医院环境中高危病原体的发生:第二部分。耐多药非发酵杆菌]。
Paulina Paluchowska, Małgorzata Skałkowska, Anna Spelak, Alicja Budak

Introduction: Multidrug-resistant gram-negative non-fermenting bacilli are an important cause of nosocomial infection. Aim of this study was to analyze the prevalence and antimicrobial susceptibility of rods of the species Acinetobacter baumannii and Pseudomonas aeruginosa, belonging to multidrug-resistant alert pathogens.

Methods: 105 (70%) strains of A. baumannii and 46 (30%) strains of P. aeruginosa were isolated from 125 patients hospitalized in the Specialistic Hospital in Krakow, in the years 2008-2010. Taken into account first isolate from the patient. The condition for inclusion in the study was the resistance or reduced susceptibility to selected groups of antibiotics, such as beta-lactams, aminoglycosides and fluoroquinolones. Bacterial identification and antimicrobial susceptibility testing were performed by automated system Vitek 2 Compact (bioMerieux, Poland). All strains were tested with phenotypic method Etest MBL (AB Biodisk, Sweden) for the presence of resistance mechanism associated with the production of metallo-beta-lactamases.

Results: Bacilli of the species A. baumannii were isolated most frequently from patients from the Department of Anesthesiology and Intensive Care (52%) and Burn Therapy Unit (25%), with clinical materials collected from the respiratory tract (51%), the wound swabs (18%), urine (11%) and blood (11%). Production of metallo-beta-lactamases was found in 24 (22.9%) strains of A. baumannii. Drugs effective against multidrug-resistant isolates of A. baumannii were colistin and amikacin. Department of anesthesiology and intensive care (59%) and unit of internal medicine (11%) were the main source of multidrug-resistant strains of P. aeruginosa. Pathogens were mainly isolated from clinical specimens collected from the respiratory tract (61%), urine (15%) and wound swabs (13%). Seven (15.2%) strains of P. aeruginosa produced the metallo-beta-lactamases. With regard to colistin and piperacillin with tazobactam was noted the highest percentage of susceptible isolates.

Conclusions: MDR bacteria belonging to alert pathogens are an important cause of many severe and difficult to treat infections which greatly increases the morbidity and mortality among hospitalized patients worldwide. Epidemiological studies and detection of local resistance patterns can provide useful information which can be used in the development of strategies to combat the rising tide of microbial antibiotic resistance.

多重耐药革兰氏阴性非发酵杆菌是医院感染的重要原因。本研究的目的是分析鲍曼不动杆菌和铜绿假单胞菌属多药耐药预警病原菌杆状体的流行情况和药敏情况。方法:从克拉科夫市专科医院2008-2010年收治的125例患者中分离出鲍曼不动杆菌105株(70%)和铜绿假单胞菌46株(30%)。首先考虑与患者隔离。纳入研究的条件是对某些抗生素的耐药性或敏感性降低,如β -内酰胺类、氨基糖苷类和氟喹诺酮类。采用Vitek 2 Compact (bioMerieux,波兰)自动系统进行细菌鉴定和药敏试验。所有菌株均采用表型法Etest MBL (AB Biodisk, Sweden)检测是否存在与金属β -内酰胺酶产生相关的耐药机制。结果:鲍曼不动杆菌以麻醉重症监护科(52%)和烧伤治疗科(25%)的患者中检出最多,临床资料分别为呼吸道(51%)、伤口拭子(18%)、尿液(11%)和血液(11%)。24株(22.9%)鲍曼不动杆菌产生金属β -内酰胺酶。对鲍曼不动杆菌多重耐药分离株有效的药物是粘菌素和阿米卡星。麻醉重症监护科(59%)和内科科室(11%)是铜绿假单胞菌多重耐药菌株的主要来源。病原菌主要来源于呼吸道(61%)、尿液(15%)和伤口拭子(13%)等临床标本。7株铜绿假单胞菌(15.2%)产生金属内酰胺酶。关于粘菌素和哌拉西林与他唑巴坦的敏感分离率最高。结论:耐多药耐药菌属高危致病菌,是造成许多重症难治性感染的重要原因,极大地增加了全球住院患者的发病率和死亡率。流行病学研究和当地耐药模式的检测可提供有用的信息,可用于制定战略,以对抗微生物抗生素耐药性的上升趋势。
{"title":"[Occurrence of alert pathogens in hospital environment Part II. Multidrug-resistant non-fermenting bacilli].","authors":"Paulina Paluchowska,&nbsp;Małgorzata Skałkowska,&nbsp;Anna Spelak,&nbsp;Alicja Budak","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Multidrug-resistant gram-negative non-fermenting bacilli are an important cause of nosocomial infection. Aim of this study was to analyze the prevalence and antimicrobial susceptibility of rods of the species Acinetobacter baumannii and Pseudomonas aeruginosa, belonging to multidrug-resistant alert pathogens.</p><p><strong>Methods: </strong>105 (70%) strains of A. baumannii and 46 (30%) strains of P. aeruginosa were isolated from 125 patients hospitalized in the Specialistic Hospital in Krakow, in the years 2008-2010. Taken into account first isolate from the patient. The condition for inclusion in the study was the resistance or reduced susceptibility to selected groups of antibiotics, such as beta-lactams, aminoglycosides and fluoroquinolones. Bacterial identification and antimicrobial susceptibility testing were performed by automated system Vitek 2 Compact (bioMerieux, Poland). All strains were tested with phenotypic method Etest MBL (AB Biodisk, Sweden) for the presence of resistance mechanism associated with the production of metallo-beta-lactamases.</p><p><strong>Results: </strong>Bacilli of the species A. baumannii were isolated most frequently from patients from the Department of Anesthesiology and Intensive Care (52%) and Burn Therapy Unit (25%), with clinical materials collected from the respiratory tract (51%), the wound swabs (18%), urine (11%) and blood (11%). Production of metallo-beta-lactamases was found in 24 (22.9%) strains of A. baumannii. Drugs effective against multidrug-resistant isolates of A. baumannii were colistin and amikacin. Department of anesthesiology and intensive care (59%) and unit of internal medicine (11%) were the main source of multidrug-resistant strains of P. aeruginosa. Pathogens were mainly isolated from clinical specimens collected from the respiratory tract (61%), urine (15%) and wound swabs (13%). Seven (15.2%) strains of P. aeruginosa produced the metallo-beta-lactamases. With regard to colistin and piperacillin with tazobactam was noted the highest percentage of susceptible isolates.</p><p><strong>Conclusions: </strong>MDR bacteria belonging to alert pathogens are an important cause of many severe and difficult to treat infections which greatly increases the morbidity and mortality among hospitalized patients worldwide. Epidemiological studies and detection of local resistance patterns can provide useful information which can be used in the development of strategies to combat the rising tide of microbial antibiotic resistance.</p>","PeriodicalId":18521,"journal":{"name":"Medycyna doswiadczalna i mikrobiologia","volume":"64 1","pages":"45-53"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30772138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Evaluation of multiplex PCR to identify the species of microorganisms from Bacillus cereus group]. [多重PCR鉴定蜡样芽孢杆菌群微生物种类的评价]。
Kamila Formińska, Aleksandra Anna Zasada, Marek Jagielski

Introduction: Bacillus genus comprises about 215 species. The most closely related are B. cereus, B. thuringiensis, B. anthracis, B. mycoides, B. pseudomycoides and B. weihenstephanensis. These bacterial species belong to the Bacillus cereus group. Identification and differentiation of Bacillus cereus group bacteria is difficult because of genetic and phenotypic similarity. Many molecular methods have already been suggested to differentiate B. cereus group members. However easier and more convenient methods are still sought. The aim of this study was to evaluate of multiplex PCR method to identify and distinguish strains of Bacillus cereus group, as proposed by Park et al. (J Microbiol Biotechnol 2007; 17: 1177-82).

Materials and method: Twenty four strains of Bacillus cereus group included B. cereus, B. anthracis, B. thuringiensis and B. weihestephanensis was examined. A multiplex-PCR assay for the differentiation of the species has been applied by using three pairs specific oligonucleotide primers based on sequences of gyrB genes which identify species from Bacillus cereus group and one pair specific primers based on sequences of groEL gene, which are used to identify Bacillus cereus group.

Results: Using a specific primers complementary to fragment of groEL gene, we received all PCR products and thus we identified Bacillus cereus group. We have not recived a specific products characteristic for each of the species. Oligonucleotide primers recognized by Park et al. as specific for each species were complementary (often 100%) for the gyrB gene sequence in almost all species of the B. cereus group.

Conclusions: The multiplex PCR method proposed by Park et al. multiplex PCR method for identification ofB. cereus group and individual bacterial species has been proved to be useful only for identification the entire group of B. cereus. This method does not provide specific identification of the individual species. Lack of specificity of the primers used in this study creates a risk of obtaining PCR product in more than one species of the entire examined group of bacteria and does not allow the precise identification to the species level.

简介:芽孢杆菌属约有215种。最接近的是蜡样芽孢杆菌、苏云金芽孢杆菌、炭疽芽孢杆菌、真菌芽孢杆菌、假菌芽孢杆菌和魏氏芽孢杆菌。这些细菌属于蜡样芽孢杆菌群。蜡样芽孢杆菌群由于遗传和表型相似,鉴定和分化困难。已经提出了许多分子方法来区分蜡样芽孢杆菌类群成员。然而,人们仍在寻找更简单、更方便的方法。本研究的目的是评价Park等人提出的多重PCR方法对蜡样芽孢杆菌群菌株的鉴定和区分(J Microbiol biotechnology 2007;17: 1177 - 82)。材料与方法:对蜡样芽孢杆菌群24株蜡样芽孢杆菌、炭疽芽孢杆菌、苏云金芽孢杆菌和卫氏芽孢杆菌进行了检测。采用基于gyrB基因序列的3对特异性引物和基于groEL基因序列的1对特异性引物,对蜡样芽孢杆菌进行了多重pcr鉴定。结果:利用与groEL基因片段互补的特异引物,获得了所有PCR产物,从而鉴定出蜡样芽孢杆菌群。我们还没有收到每个品种的具体产品特征。Park等人识别的每个物种特异性的寡核苷酸引物与几乎所有蜡样芽孢杆菌种群的gyrB基因序列互补(通常为100%)。结论:Park等人提出的多重PCR方法可用于b。蜡样芽孢杆菌群和单个菌种已被证明仅对整个蜡样芽孢杆菌群的鉴定有用。这种方法不提供个别物种的具体鉴定。本研究中使用的引物缺乏特异性,造成在整个被检查细菌群中获得多个物种的PCR产物的风险,并且不允许在物种水平上进行精确鉴定。
{"title":"[Evaluation of multiplex PCR to identify the species of microorganisms from Bacillus cereus group].","authors":"Kamila Formińska,&nbsp;Aleksandra Anna Zasada,&nbsp;Marek Jagielski","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Bacillus genus comprises about 215 species. The most closely related are B. cereus, B. thuringiensis, B. anthracis, B. mycoides, B. pseudomycoides and B. weihenstephanensis. These bacterial species belong to the Bacillus cereus group. Identification and differentiation of Bacillus cereus group bacteria is difficult because of genetic and phenotypic similarity. Many molecular methods have already been suggested to differentiate B. cereus group members. However easier and more convenient methods are still sought. The aim of this study was to evaluate of multiplex PCR method to identify and distinguish strains of Bacillus cereus group, as proposed by Park et al. (J Microbiol Biotechnol 2007; 17: 1177-82).</p><p><strong>Materials and method: </strong>Twenty four strains of Bacillus cereus group included B. cereus, B. anthracis, B. thuringiensis and B. weihestephanensis was examined. A multiplex-PCR assay for the differentiation of the species has been applied by using three pairs specific oligonucleotide primers based on sequences of gyrB genes which identify species from Bacillus cereus group and one pair specific primers based on sequences of groEL gene, which are used to identify Bacillus cereus group.</p><p><strong>Results: </strong>Using a specific primers complementary to fragment of groEL gene, we received all PCR products and thus we identified Bacillus cereus group. We have not recived a specific products characteristic for each of the species. Oligonucleotide primers recognized by Park et al. as specific for each species were complementary (often 100%) for the gyrB gene sequence in almost all species of the B. cereus group.</p><p><strong>Conclusions: </strong>The multiplex PCR method proposed by Park et al. multiplex PCR method for identification ofB. cereus group and individual bacterial species has been proved to be useful only for identification the entire group of B. cereus. This method does not provide specific identification of the individual species. Lack of specificity of the primers used in this study creates a risk of obtaining PCR product in more than one species of the entire examined group of bacteria and does not allow the precise identification to the species level.</p>","PeriodicalId":18521,"journal":{"name":"Medycyna doswiadczalna i mikrobiologia","volume":"64 2","pages":"101-8"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30982466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Development of duplex real-time PCR assay for identification of influenza viruses of subtype A(H1)pdm09 and A(H3)]. [建立A(H1)pdm09和A(H3)亚型流感病毒的双工实时PCR鉴定方法]。
Ilona Stefańska, Tomasz Dzieciatkowski, Lidia B Brydak, Magdalena Romanowska

Introduction: Among different laboratory techniques used in influenza surveillance, methods based on molecular biology, such as real-time PCR, play increasingly important role. They allow detection and identification of viruses currently circulating in human population and responsible for infections and diseases. The aim of the study was to develop duplex real-time PCR assay for detection and differentiation of influenza virus subtype A(H1N1) pdm09 and A(H3N2).

Methods: Specific primers targeting a highly conservative region ofhaemagglutinin gene and a dual-color TaqMan probes, labeled with fluorophore JOE (560 nm) and quencher BHQ-1 or CalFluor Red 610 (610 nm) and BHQ-2 were designed. The specificity of duplex reaction was evaluated using RNA isolated from reference strains of influenza virus A(H1N1)pdm09, A(H3N2), A(H1N1) and A(H5N1), B and other respiratory pathogens. Sensitivity of the assay was tested using serial dilutions ofplasmid constructs carrying fragment of specific viral HA gene, in range between 10 and 10(5) copies/sample. A number of 116 clinical samples were tested using developed duplex qPCR assay in comparison with the CDC monoplex assay,

Results: Positive duplex qPCR results were obtained only in samples containing RNA of influenza viruses of a specific subtype. The limit of detection (LOD) of developed method amounted up to 27 copies/sample for A(H1N1)pdm09 and up to 37 copies/sample for A(H3N2).

Conclusions: The results show that developed TaqMan-based duplex qPCR assay is a valuable diagnostic tool in influenza virus surveillance for using in direct study of clinical specimens as well as identification of isolated strains of influenza virus.

在流感监测中使用的各种实验室技术中,基于分子生物学的方法,如实时PCR,发挥着越来越重要的作用。它们可以检测和识别目前在人群中传播并导致感染和疾病的病毒。本研究的目的是建立检测和区分甲型H1N1流感病毒亚型pdm09和甲型H3N2的双链实时PCR方法。方法:设计针对血凝素基因高度保守区域的特异性引物和双色TaqMan探针,分别用荧光团JOE (560 nm)和淬灭剂BHQ-1或CalFluor Red 610 (610 nm)和BHQ-2标记。采用流感病毒A(H1N1)pdm09、A(H3N2)、A(H1N1)和A(H5N1)、B和其他呼吸道病原体参比株分离的RNA评价双反应的特异性。使用携带特定病毒HA基因片段的质粒构建物的连续稀释,在10到10(5)个拷贝/样本的范围内,测试了该试验的灵敏度。使用开发的双工qPCR方法对116个临床样本进行了检测,并与CDC单工pcr方法进行了比较。结果:双工qPCR结果仅在含有特定亚型流感病毒RNA的样本中获得阳性结果。该方法的检出限(LOD)对A(H1N1)pdm09和A(H3N2) pdm09的检出限分别为27份和37份。结论:基于taqman的双链qPCR方法可用于临床标本的直接研究和流感病毒分离株的鉴定,是一种有价值的流感病毒监测诊断工具。
{"title":"[Development of duplex real-time PCR assay for identification of influenza viruses of subtype A(H1)pdm09 and A(H3)].","authors":"Ilona Stefańska,&nbsp;Tomasz Dzieciatkowski,&nbsp;Lidia B Brydak,&nbsp;Magdalena Romanowska","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Among different laboratory techniques used in influenza surveillance, methods based on molecular biology, such as real-time PCR, play increasingly important role. They allow detection and identification of viruses currently circulating in human population and responsible for infections and diseases. The aim of the study was to develop duplex real-time PCR assay for detection and differentiation of influenza virus subtype A(H1N1) pdm09 and A(H3N2).</p><p><strong>Methods: </strong>Specific primers targeting a highly conservative region ofhaemagglutinin gene and a dual-color TaqMan probes, labeled with fluorophore JOE (560 nm) and quencher BHQ-1 or CalFluor Red 610 (610 nm) and BHQ-2 were designed. The specificity of duplex reaction was evaluated using RNA isolated from reference strains of influenza virus A(H1N1)pdm09, A(H3N2), A(H1N1) and A(H5N1), B and other respiratory pathogens. Sensitivity of the assay was tested using serial dilutions ofplasmid constructs carrying fragment of specific viral HA gene, in range between 10 and 10(5) copies/sample. A number of 116 clinical samples were tested using developed duplex qPCR assay in comparison with the CDC monoplex assay,</p><p><strong>Results: </strong>Positive duplex qPCR results were obtained only in samples containing RNA of influenza viruses of a specific subtype. The limit of detection (LOD) of developed method amounted up to 27 copies/sample for A(H1N1)pdm09 and up to 37 copies/sample for A(H3N2).</p><p><strong>Conclusions: </strong>The results show that developed TaqMan-based duplex qPCR assay is a valuable diagnostic tool in influenza virus surveillance for using in direct study of clinical specimens as well as identification of isolated strains of influenza virus.</p>","PeriodicalId":18521,"journal":{"name":"Medycyna doswiadczalna i mikrobiologia","volume":"64 2","pages":"129-37"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30981857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[In vitro resistance development in Acinetobacter baumannii to sulbactam and cefoperazone]. 鲍曼不动杆菌对舒巴坦和头孢哌酮的体外耐药进展。
Piotr Wieczorek, Paweł Sacha, Dominika Ojdana, Robert Milewski, Anna Jurczak, Katarzyna Kaczyńska, Elzbieta Tryniszewska

Introduction: Majority of nosocomial Acinetobacter baumannii strains are highly resistant to many available groups of antibiotics, causing therapy of infections the clinical challenge. The aim of study was to estimate of resistance development to sulbactam, cefoperazone and cefoperazone/sulbactam in Acinetobacter baumannii clinical strains.

Methods: Five Acinetobacter baumannii strains (Acb1, Acb2, Acb4, Acb13 and Acb25) were identified by the VITEK 2 GN card and the automatic system VITEK 2 according to the procedure and following the producer's instructions. Additionaly, the belonging of the strains to the species was confirmed by the presence of the bla(OXA-51-like) gene. Initial and after antibiotic exposure MIC values of sulbactam, cefoperazone and cefoperazone/sulbactam were determined by using a broth microdilution method. Antibiotic pressure of examined strains was performed in Mueller-Hinton broth containing 0,5x, 0,9x and 2x initial MIC of individual compounds during six-day passages and next six-day passages without antibiotic presence. The Mann-Whitney U test and Kruskal-Wallis non-prarametric Anova test were used to statistical analysis.

Results: Serial passaging of Acinetobacter baumannii strains in the presence of antibiotics caused permanent increasing MIC value independently of used concentrations in the majority of examined strains. The highest MIC value increase of sulbactam was found in Acb4 strain. Even after two passages this isolate changed MIC from 0.5 microg/ml to 4 microg/ml (increase about four levels of concentration). Moreover, after incubation in 0.9x MIC concentration similar observation was noted. No normalization of MIC value of sulbactam after incubation during next six passages without sulbactam was observed. In case of cefoperazone the highest levels of induction were noted in Acb1, Acb13 and Acb25 strains. In these strains, after two passages in presence of cefoperazone (2xMIC) the exceedance of minimal of growth concentration over the highest examined concentration was observed. Similar effects were observed in Acbl strain after stimulation with 0.9x and 0.5x MIC cefoperazone. Return of initial MIC values was received only after induction with 0.5 x MIC cefoperazone. In some cases, no opportunities for evaluation of resistance development was noted, because during stimulation with 2x MIC of used antibiotics concentarations, bactericidal effect was found.

Conclusions: Sulbactam, cefoperazone and cefoperazone/sulbactam rapidly induce increasing of resistance in Acinetobacter baumannii clinical isolates. Statistically essential MIC increase after using higher concentration than lower was showed. This effect was particularly visible in the case of stimulation of cefoperazone/sulbactam combination.

大多数医院感染的鲍曼不动杆菌菌株对许多现有抗生素具有高度耐药性,给感染的治疗带来了临床挑战。本研究的目的是评估鲍曼不动杆菌临床菌株对舒巴坦、头孢哌酮和头孢哌酮/舒巴坦的耐药情况。方法:采用VITEK 2 GN卡片和VITEK 2自动检测系统,按照生产厂家的说明书,对5株鲍曼不动杆菌(Acb1、Acb2、Acb4、Acb13和Acb25)进行鉴定。此外,bla(oxa -51样)基因的存在证实了菌株属于该物种。采用微量肉汤稀释法测定舒巴坦、头孢哌酮和头孢哌酮/舒巴坦抗生素暴露前后的MIC值。在含有0、5、0、9和2倍初始MIC的Mueller-Hinton肉汤中对被检查的菌株进行抗生素压力测试,为期6天,接下来的6天不含抗生素。采用Mann-Whitney U检验和Kruskal-Wallis非参数方差分析进行统计分析。结果:鲍曼不动杆菌在抗生素存在下的连续传代导致大多数被检测菌株的MIC值永久升高,而与使用的浓度无关。舒巴坦的MIC值在Acb4菌株中增幅最大。即使在两次传代后,该分离物也将MIC从0.5微克/毫升改变为4微克/毫升(浓度增加了大约四个级别)。在0.9倍MIC浓度下孵育后,也有类似的观察结果。在接下来的六次不使用舒巴坦的孵育过程中,未观察到舒巴坦的MIC值正常化。头孢哌酮对Acb1、Acb13和Acb25菌株的诱导水平最高。在这些菌株中,在头孢哌酮(2xMIC)存在两代后,观察到最小生长浓度超过最高检测浓度。0.9倍、0.5倍MIC头孢哌酮刺激Acbl菌株后也有类似效果。只有在用0.5倍MIC头孢哌酮诱导后才能获得初始MIC值的返回。在某些情况下,没有机会评估耐药性的发展,因为在使用2倍MIC的抗生素浓度刺激时,发现了杀菌作用。结论:舒巴坦、头孢哌酮及头孢哌酮/舒巴坦可快速诱导鲍曼不动杆菌临床分离株耐药增加。使用较高浓度后,MIC明显高于较低浓度。这种效果在头孢哌酮/舒巴坦联合刺激的情况下尤其明显。
{"title":"[In vitro resistance development in Acinetobacter baumannii to sulbactam and cefoperazone].","authors":"Piotr Wieczorek,&nbsp;Paweł Sacha,&nbsp;Dominika Ojdana,&nbsp;Robert Milewski,&nbsp;Anna Jurczak,&nbsp;Katarzyna Kaczyńska,&nbsp;Elzbieta Tryniszewska","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Majority of nosocomial Acinetobacter baumannii strains are highly resistant to many available groups of antibiotics, causing therapy of infections the clinical challenge. The aim of study was to estimate of resistance development to sulbactam, cefoperazone and cefoperazone/sulbactam in Acinetobacter baumannii clinical strains.</p><p><strong>Methods: </strong>Five Acinetobacter baumannii strains (Acb1, Acb2, Acb4, Acb13 and Acb25) were identified by the VITEK 2 GN card and the automatic system VITEK 2 according to the procedure and following the producer's instructions. Additionaly, the belonging of the strains to the species was confirmed by the presence of the bla(OXA-51-like) gene. Initial and after antibiotic exposure MIC values of sulbactam, cefoperazone and cefoperazone/sulbactam were determined by using a broth microdilution method. Antibiotic pressure of examined strains was performed in Mueller-Hinton broth containing 0,5x, 0,9x and 2x initial MIC of individual compounds during six-day passages and next six-day passages without antibiotic presence. The Mann-Whitney U test and Kruskal-Wallis non-prarametric Anova test were used to statistical analysis.</p><p><strong>Results: </strong>Serial passaging of Acinetobacter baumannii strains in the presence of antibiotics caused permanent increasing MIC value independently of used concentrations in the majority of examined strains. The highest MIC value increase of sulbactam was found in Acb4 strain. Even after two passages this isolate changed MIC from 0.5 microg/ml to 4 microg/ml (increase about four levels of concentration). Moreover, after incubation in 0.9x MIC concentration similar observation was noted. No normalization of MIC value of sulbactam after incubation during next six passages without sulbactam was observed. In case of cefoperazone the highest levels of induction were noted in Acb1, Acb13 and Acb25 strains. In these strains, after two passages in presence of cefoperazone (2xMIC) the exceedance of minimal of growth concentration over the highest examined concentration was observed. Similar effects were observed in Acbl strain after stimulation with 0.9x and 0.5x MIC cefoperazone. Return of initial MIC values was received only after induction with 0.5 x MIC cefoperazone. In some cases, no opportunities for evaluation of resistance development was noted, because during stimulation with 2x MIC of used antibiotics concentarations, bactericidal effect was found.</p><p><strong>Conclusions: </strong>Sulbactam, cefoperazone and cefoperazone/sulbactam rapidly induce increasing of resistance in Acinetobacter baumannii clinical isolates. Statistically essential MIC increase after using higher concentration than lower was showed. This effect was particularly visible in the case of stimulation of cefoperazone/sulbactam combination.</p>","PeriodicalId":18521,"journal":{"name":"Medycyna doswiadczalna i mikrobiologia","volume":"64 1","pages":"55-62"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30772139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Rapid identification of Yersinia enterocolitica by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS)]. [基质辅助激光解吸/电离飞行时间质谱(MALDI-TOF MS)快速鉴定小肠结肠炎耶尔森菌]。
Katarzyna Zacharczuk, Agnieszka Sulikowska, Ewa Nowacka, Jolanta Szych, Rafał Gierczyński

Introduction: Yersinia enterocolitica includes both human pathogenic and non-pathogenic strains. The pathogenic strains belong to two evolutionary lineages: European and American, of mild- and high- pthogenicity, respectively. Y. enterocolitica European bioserotypes 4/O3 and 2/O9 are one of the major etiological agents of human yersiniosis worldwide. American lineage Y. enterocolitica bioserotype 1B/O8 has recently emerged in Europe. Since 2004 this high-pathogenicity bioserotype is increasingly isolated from humans in Poland. The rapid and accurate identification of pathogenic Y. enterocolitica strains is essential for diagnostic purposes. The aim of this study was to assess the usefulness of commercially available MALDI-TOF mass spectroscopy for Y. enterocolitica identification and subtyping.

Methods: A total of 33 strains of Y. enterocolitica belonging to bioserotype: 1B/O8 (n=2), 4/O3 (n=25) and 2/O9 (n=6) isolated from clinical specimens in Poland and 10 reference Y. enterocolitica 1B/O8 strains (Institute Pasteur, France) were used in this study. The identification of the Y. enterocolitica strains by MALDI-TOF MS was performed on MALDI Biotyper system (Bruker Daltonics, USA) with flexControl 3.0 software (Bruker Daltonics) according with the manufacturer's instruction.

Results: All of the tested Y. enterocolitica strains were correctly identified at the species level. However, American and European strains were not differentiated.

Conclusions: Our data indicate that MALDI-TOF MS can be used as a first-line method for rapid identification of Y. enterocolitica strains at the species level in clinical microbiology laboratories.

简介:小肠结肠炎耶尔森菌包括人类致病性和非致病性菌株。致病菌株属于两个进化谱系:欧洲和美洲,分别具有轻度和高致病性。小肠结肠炎耶尔森菌欧洲生物血清型4/O3和2/O9是世界范围内人类耶尔森菌病的主要病原之一。美国系小肠结肠炎菌生物血清型1B/O8最近在欧洲出现。自2004年以来,波兰越来越多地从人类中分离出这种高致病性生物血清型。快速准确地鉴定致病性小肠结肠炎耶氏菌菌株对诊断至关重要。本研究的目的是评估市售MALDI-TOF质谱对小肠结肠炎菌鉴定和分型的有用性。方法:采用波兰临床分离的33株生物血清型1B/O8 (n=2)、4/O3 (n=25)和2/O9 (n=6)肠结肠炎耶夫氏菌和法国巴斯德研究所10株小肠结肠炎耶夫氏菌1B/O8作为对照。MALDI- tof MS在MALDI Biotyper系统(Bruker Daltonics, USA)上使用flexControl 3.0软件(Bruker Daltonics),按照制造商的说明书进行鉴定。结果:所有检测的小肠结肠炎耶氏菌在种水平上均被正确鉴定。然而,美洲和欧洲菌株没有分化。结论:MALDI-TOF质谱法可作为临床微生物实验室快速鉴定小肠结肠炎耶夫菌种水平的一线方法。
{"title":"[Rapid identification of Yersinia enterocolitica by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS)].","authors":"Katarzyna Zacharczuk,&nbsp;Agnieszka Sulikowska,&nbsp;Ewa Nowacka,&nbsp;Jolanta Szych,&nbsp;Rafał Gierczyński","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Yersinia enterocolitica includes both human pathogenic and non-pathogenic strains. The pathogenic strains belong to two evolutionary lineages: European and American, of mild- and high- pthogenicity, respectively. Y. enterocolitica European bioserotypes 4/O3 and 2/O9 are one of the major etiological agents of human yersiniosis worldwide. American lineage Y. enterocolitica bioserotype 1B/O8 has recently emerged in Europe. Since 2004 this high-pathogenicity bioserotype is increasingly isolated from humans in Poland. The rapid and accurate identification of pathogenic Y. enterocolitica strains is essential for diagnostic purposes. The aim of this study was to assess the usefulness of commercially available MALDI-TOF mass spectroscopy for Y. enterocolitica identification and subtyping.</p><p><strong>Methods: </strong>A total of 33 strains of Y. enterocolitica belonging to bioserotype: 1B/O8 (n=2), 4/O3 (n=25) and 2/O9 (n=6) isolated from clinical specimens in Poland and 10 reference Y. enterocolitica 1B/O8 strains (Institute Pasteur, France) were used in this study. The identification of the Y. enterocolitica strains by MALDI-TOF MS was performed on MALDI Biotyper system (Bruker Daltonics, USA) with flexControl 3.0 software (Bruker Daltonics) according with the manufacturer's instruction.</p><p><strong>Results: </strong>All of the tested Y. enterocolitica strains were correctly identified at the species level. However, American and European strains were not differentiated.</p><p><strong>Conclusions: </strong>Our data indicate that MALDI-TOF MS can be used as a first-line method for rapid identification of Y. enterocolitica strains at the species level in clinical microbiology laboratories.</p>","PeriodicalId":18521,"journal":{"name":"Medycyna doswiadczalna i mikrobiologia","volume":"64 2","pages":"123-8"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30981856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The incidence of high-level aminoglicoside and high-level beta-lactam resistance among enterococcal strains of various origin]. [不同来源肠球菌菌株中高水平氨基甘糖苷和高水平β -内酰胺耐药的发生率]。
Irena Aleksandrowicz

Introduction: Intensive use of broad-spectrum antibiotics is responsible for conversion of enterococci from commensal bacteria to opportunistic nosocomial pathogenes. The serious infections caused by them are often treated with synergistic bacteriocidal combination of beta-lactam and aminoglycoside. The presence of high-level aminoglikosyde (HLAR) and/or beta-lactam (HLPR) resistance makes this treatment ineffective.

Methods: This study investigated the differences in occurance of HLAR and/or HLPR among groups of enterococi isolated from: rectal swabs of healthy volunteers, samples of food and clinical specimens. Enterococci were identified by 6.5% NaCl tolerance and growth on bile-esculin agar with esculin hydrolysis. Species-level identification was made on the basis of motility, pigmentation, arginine hydrolysis, growth on tellurite and formation of acid in mannitol, sorbitol, sucrose, arabinose, raffinose and sorbose broth (according to the Facklam's and Sahm's scheme). High-level resistance were determined to penicillins (> 100 microg/ml), gentamycin (> 500 microg/ml) and streptomycin (> 2000 microg/ml).

Results: Although differences in species prevalence varied by source, E. faecalis was the common enterococcal species in all samples (> 70%), followed by E. faecium (10%-20.4%) and E. durans (4.2%-8.45%). E. faecalis varians, E. pseudoavium and E. raffinossus were isolated rarely. Analysis of 452 enterococcal strains revealed the presence HLAR in all groups, but HLPR was not present in samples of food. In community the HLR was greatest for streptomycin, but among hospital isolations-HLR both to streptomycin and gentamycin were most common. Such resistance was more frequent in E. faecium than in E. faecalis. HLR to kanamycin was not found.

Conclusions: This study shows that high-level resistance to aminoglycoside and/or beta-lactam of enterococci may play an important role in public health. Little is known about the prevalence, risk factors and reservoirs for resistance enterococci outside of the hospital. A comparison of the resistance determinants in isolates from healthy volunteers with the genes responsible for resistance in isolates from patients.

广泛使用广谱抗生素可导致肠球菌从共生菌转化为机会性医院致病菌。它们引起的严重感染常采用-内酰胺和氨基糖苷协同杀菌联合治疗。高水平氨基利科苷(HLAR)和/或β -内酰胺(HLPR)耐药性的存在使这种治疗无效。方法:本研究调查了从健康志愿者直肠拭子、食物样本和临床标本中分离的肠球菌在hla和/或HLPR发生率上的差异。通过对6.5% NaCl的耐受性和在胆汁-esculin琼脂上通过esculin水解生长鉴定出肠球菌。根据其在甘露醇、山梨醇、蔗糖、阿拉伯糖、棉子糖和山梨糖肉汤中的运动性、色素沉着、精氨酸水解、在tellite上的生长和酸的形成(根据Facklam’s和Sahm’s方案)进行了种水平的鉴定。对青霉素(> 100 μ g/ml)、庆大霉素(> 500 μ g/ml)和链霉素(> 2000 μ g/ml)均呈高耐药。结果:虽然不同来源的肠球菌种类患病率存在差异,但所有样本中常见的肠球菌种类为粪肠球菌(> 70%),其次为粪肠球菌(10% ~ 20.4%)和durans肠球菌(4.2% ~ 8.45%)。变异粪肠杆菌、假鸟肠杆菌和棉毛肠杆菌分离较少。对452株肠球菌菌株的分析显示,所有组中均存在HLPR,但食物样本中未发现HLPR。社区对链霉素的HLR最高,但在医院分离株中,链霉素和庆大霉素的HLR最常见。粪肠杆菌的耐药率高于粪肠杆菌。未发现卡那霉素的HLR。结论:本研究表明肠球菌对氨基糖苷和/或β -内酰胺的高水平耐药性可能在公共卫生中发挥重要作用。目前对医院外肠球菌的流行、危险因素和耐药宿主知之甚少。健康志愿者分离株的耐药决定因素与患者分离株的耐药基因的比较。
{"title":"[The incidence of high-level aminoglicoside and high-level beta-lactam resistance among enterococcal strains of various origin].","authors":"Irena Aleksandrowicz","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Intensive use of broad-spectrum antibiotics is responsible for conversion of enterococci from commensal bacteria to opportunistic nosocomial pathogenes. The serious infections caused by them are often treated with synergistic bacteriocidal combination of beta-lactam and aminoglycoside. The presence of high-level aminoglikosyde (HLAR) and/or beta-lactam (HLPR) resistance makes this treatment ineffective.</p><p><strong>Methods: </strong>This study investigated the differences in occurance of HLAR and/or HLPR among groups of enterococi isolated from: rectal swabs of healthy volunteers, samples of food and clinical specimens. Enterococci were identified by 6.5% NaCl tolerance and growth on bile-esculin agar with esculin hydrolysis. Species-level identification was made on the basis of motility, pigmentation, arginine hydrolysis, growth on tellurite and formation of acid in mannitol, sorbitol, sucrose, arabinose, raffinose and sorbose broth (according to the Facklam's and Sahm's scheme). High-level resistance were determined to penicillins (> 100 microg/ml), gentamycin (> 500 microg/ml) and streptomycin (> 2000 microg/ml).</p><p><strong>Results: </strong>Although differences in species prevalence varied by source, E. faecalis was the common enterococcal species in all samples (> 70%), followed by E. faecium (10%-20.4%) and E. durans (4.2%-8.45%). E. faecalis varians, E. pseudoavium and E. raffinossus were isolated rarely. Analysis of 452 enterococcal strains revealed the presence HLAR in all groups, but HLPR was not present in samples of food. In community the HLR was greatest for streptomycin, but among hospital isolations-HLR both to streptomycin and gentamycin were most common. Such resistance was more frequent in E. faecium than in E. faecalis. HLR to kanamycin was not found.</p><p><strong>Conclusions: </strong>This study shows that high-level resistance to aminoglycoside and/or beta-lactam of enterococci may play an important role in public health. Little is known about the prevalence, risk factors and reservoirs for resistance enterococci outside of the hospital. A comparison of the resistance determinants in isolates from healthy volunteers with the genes responsible for resistance in isolates from patients.</p>","PeriodicalId":18521,"journal":{"name":"Medycyna doswiadczalna i mikrobiologia","volume":"64 1","pages":"11-8"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30772178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Candida and Aspergillus infections in the light of a new list of alarm factors on the example of the Lodz Medical University Hospital No. 1]. [以罗兹医科大学第一医院为例,念珠菌和曲霉菌感染的新预警因素]。
Ewa Tyczkowska-Sieroń, Anna Bartoszko-Tyczkowska

Introduction: In 2011, the Polish Ministry of Health introduced Candida sp. resistant to fluconazole and Aspergillus sp. to the list of Alarm Factors as alert pathogens. The purpose of this paper is to confirm the validity of continuous monitoring of fungal infections caused by the pathogens mentioned above. The role offluconazole therapy in the Candida sp. infections is also discussed. The analysis of the fungal infections is performed based on the results obtained in the University Clinic Hospital (UCH) No. 1 in Lodz in 2009-2011.

Methods: The swabs were plated on Sabouraud's agar. Body fluids and blood were incubated in an automated system Bactec 9050. Yeast ID Phoenix BD panels were used to determine the species of fungi. In turn, antimicrobial susceptibility testing was carried out by E-tests (bioMerieux).

Results: In the analysis of fungal infections occurring among patients in the UCH No. 1 in Lodz in 2009-2011, C. albicans, C. non-albicans and Aspergillus sp. infections are taken into account. This analysis is performed based on relations of the number of infections (per 100 patients) versus six-month periods. As one can see in Fig. 1, a clear, linear and statistically significant increase in the number of C. albicans and C. non-albicans infections is observed throughout the entire time period under discussion. On the other hand, the number of Aspergillus sp. infections remains at an almost constant low level. The more detailed analysis of fungal infections in the different hospital units, which are particularly exposed to this type of infections (Figs. 2-6), shows that there is a clear correlation between the number of C. non-albicans infections and the frequency of therapy with fluconazole.

Conclusions: The results presented in this paper show in the example of the UCH No. 1 in Lodz that the number of infections caused by C. albicans and C. non-albicans resistant to fluconazole is clearly increasing in a hospital environment in recent years, which is a great clinical problem. Although the number of Aspergillus sp. infections is relatively much lower in comparison to that of Candidia sp., these infections also constitute a problem of clinical importance. In light of the presented analysis, it should be assessed positively the fact that Candida sp. resistant to fluconazole and Aspergillus sp. are considered to be alert pathogens that require the continuous monitoring.

2011年,波兰卫生部将对氟康唑耐药的念珠菌和曲霉菌列入警报因素清单,作为警报病原体。本文的目的是确认对上述病原菌引起的真菌感染进行连续监测的有效性。本文还讨论了氟康唑治疗念珠菌感染的作用。真菌感染的分析基于2009-2011年在罗兹第一大学诊所医院(UCH)获得的结果。方法:将拭子涂于沙伯罗琼脂上。体液和血液在Bactec 9050自动系统中孵育。使用酵母ID Phoenix BD板确定真菌种类。反过来,由e -test (bioMerieux)进行抗菌药物敏感性试验。结果:在2009-2011年罗兹第一医院患者真菌感染分析中,考虑了白色念珠菌、非白色念珠菌和曲霉菌感染。该分析是根据感染数量(每100名患者)与6个月期间的关系进行的。如图1所示,在讨论的整个时间段内,观察到白色念珠菌和非白色念珠菌感染数量的明显、线性和统计学显著增加。另一方面,曲霉菌感染的数量保持在一个几乎恒定的低水平。对不同医院单位真菌感染的更详细分析表明,非白色念珠菌感染的数量与氟康唑治疗的频率之间存在明显的相关性,这些医院单位特别容易受到这类感染(图2-6)。结论:本文以罗兹第一医院为例,结果显示近年来医院环境中由白色念珠菌和氟康唑耐药非白色念珠菌引起的感染数量明显增加,这是一个很大的临床问题。虽然与念珠菌相比,曲霉菌感染的数量相对要低得多,但这些感染也构成了一个具有临床重要性的问题。根据所提出的分析,应积极评估对氟康唑耐药的念珠菌和曲霉属警惕病原体,需要持续监测。
{"title":"[Candida and Aspergillus infections in the light of a new list of alarm factors on the example of the Lodz Medical University Hospital No. 1].","authors":"Ewa Tyczkowska-Sieroń,&nbsp;Anna Bartoszko-Tyczkowska","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>In 2011, the Polish Ministry of Health introduced Candida sp. resistant to fluconazole and Aspergillus sp. to the list of Alarm Factors as alert pathogens. The purpose of this paper is to confirm the validity of continuous monitoring of fungal infections caused by the pathogens mentioned above. The role offluconazole therapy in the Candida sp. infections is also discussed. The analysis of the fungal infections is performed based on the results obtained in the University Clinic Hospital (UCH) No. 1 in Lodz in 2009-2011.</p><p><strong>Methods: </strong>The swabs were plated on Sabouraud's agar. Body fluids and blood were incubated in an automated system Bactec 9050. Yeast ID Phoenix BD panels were used to determine the species of fungi. In turn, antimicrobial susceptibility testing was carried out by E-tests (bioMerieux).</p><p><strong>Results: </strong>In the analysis of fungal infections occurring among patients in the UCH No. 1 in Lodz in 2009-2011, C. albicans, C. non-albicans and Aspergillus sp. infections are taken into account. This analysis is performed based on relations of the number of infections (per 100 patients) versus six-month periods. As one can see in Fig. 1, a clear, linear and statistically significant increase in the number of C. albicans and C. non-albicans infections is observed throughout the entire time period under discussion. On the other hand, the number of Aspergillus sp. infections remains at an almost constant low level. The more detailed analysis of fungal infections in the different hospital units, which are particularly exposed to this type of infections (Figs. 2-6), shows that there is a clear correlation between the number of C. non-albicans infections and the frequency of therapy with fluconazole.</p><p><strong>Conclusions: </strong>The results presented in this paper show in the example of the UCH No. 1 in Lodz that the number of infections caused by C. albicans and C. non-albicans resistant to fluconazole is clearly increasing in a hospital environment in recent years, which is a great clinical problem. Although the number of Aspergillus sp. infections is relatively much lower in comparison to that of Candidia sp., these infections also constitute a problem of clinical importance. In light of the presented analysis, it should be assessed positively the fact that Candida sp. resistant to fluconazole and Aspergillus sp. are considered to be alert pathogens that require the continuous monitoring.</p>","PeriodicalId":18521,"journal":{"name":"Medycyna doswiadczalna i mikrobiologia","volume":"64 3","pages":"245-53"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40208204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medycyna doswiadczalna i mikrobiologia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1